Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
Clinical trial NCT07621809 · RECRUITING
Trial details
- NCT number
- NCT07621809
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-16
- Primary completion
- 2029-08-14
- Enrollment
- 570
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.